| Primary |
| Insomnia |
23.4% |
| Product Used For Unknown Indication |
18.3% |
| Sleep Disorder |
13.1% |
| Intentional Overdose |
5.7% |
| Hypothyroidism |
4.6% |
| Hypertension |
3.4% |
| Intentional Self-injury |
3.4% |
| Back Pain |
2.9% |
| Blood Cholesterol Increased |
2.9% |
| Ill-defined Disorder |
2.9% |
| Blood Pressure |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Thyroid Disorder |
2.3% |
| Anxiety |
1.7% |
| Cardiac Disorder |
1.7% |
| Depression |
1.7% |
| Pain |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Sedative Therapy |
1.7% |
|
| Drug Ineffective |
37.0% |
| Suicide Attempt |
7.6% |
| Sopor |
6.5% |
| Death |
4.3% |
| Overdose |
4.3% |
| Somnolence |
4.3% |
| Suicidal Ideation |
4.3% |
| Malaise |
3.3% |
| Product Quality Issue |
3.3% |
| Torsade De Pointes |
3.3% |
| Drug Hypersensitivity |
2.2% |
| Drug Screen Negative |
2.2% |
| Hallucination |
2.2% |
| Non-cardiogenic Pulmonary Oedema |
2.2% |
| Oedema |
2.2% |
| Pain |
2.2% |
| Poisoning |
2.2% |
| Pruritus |
2.2% |
| Syncope |
2.2% |
| Therapeutic Response Unexpected With Drug Substitution |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
41.2% |
| Insomnia |
13.2% |
| Drug Use For Unknown Indication |
10.8% |
| Hypertension |
6.9% |
| Alcoholism |
5.7% |
| Pain |
3.6% |
| Depression |
2.9% |
| Bipolar I Disorder |
1.8% |
| Muscle Spasms |
1.6% |
| Glaucoma |
1.4% |
| Anger |
1.3% |
| Restlessness |
1.3% |
| Bipolar Ii Disorder |
1.2% |
| Sleep Disorder |
1.2% |
| Anxiety |
1.1% |
| Hiv Infection |
1.0% |
| Schizophrenia |
1.0% |
| Sedation |
1.0% |
| Blood Cholesterol Increased |
0.8% |
| Analgesic Therapy |
0.7% |
|
| Completed Suicide |
13.0% |
| Sopor |
9.8% |
| Toxicity To Various Agents |
9.8% |
| Vestibular Disorder |
9.8% |
| Overdose |
7.3% |
| Blepharospasm |
6.5% |
| Suicide Attempt |
6.5% |
| Somnolence |
4.9% |
| Multiple Drug Overdose |
4.1% |
| Altered State Of Consciousness |
3.3% |
| Death |
3.3% |
| Abnormal Behaviour |
2.4% |
| Carcinoid Tumour Of The Gastrointestinal Tract |
2.4% |
| Cardiac Failure Congestive |
2.4% |
| Condition Aggravated |
2.4% |
| Drug Ineffective |
2.4% |
| Parasomnia |
2.4% |
| Pruritus |
2.4% |
| Respiratory Arrest |
2.4% |
| Restlessness |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.0% |
| Product Used For Unknown Indication |
17.0% |
| Insomnia |
9.6% |
| Rheumatoid Arthritis |
8.4% |
| Hypertension |
6.8% |
| Depression |
5.4% |
| Pain |
3.6% |
| Anxiety |
3.1% |
| Diffuse Large B-cell Lymphoma |
3.0% |
| Prophylaxis |
3.0% |
| Constipation |
2.7% |
| Schizophrenia |
2.6% |
| Sleep Disorder |
2.4% |
| Asthma |
1.9% |
| Hypersensitivity |
1.8% |
| Diabetes Mellitus |
1.8% |
| Gastritis |
1.6% |
| Atrial Fibrillation |
1.5% |
| Osteoporosis |
1.5% |
| Breast Cancer |
1.4% |
|
| Vomiting |
13.6% |
| Weight Increased |
6.8% |
| Pain |
6.3% |
| Subarachnoid Haemorrhage |
5.9% |
| Pyrexia |
5.4% |
| Urinary Tract Infection |
5.4% |
| Weight Decreased |
5.4% |
| Pneumonia |
5.0% |
| Somnolence |
5.0% |
| White Blood Cell Count Increased |
4.5% |
| Drug Ineffective |
4.1% |
| Rheumatoid Arthritis |
4.1% |
| Diverticulitis Intestinal Haemorrhagic |
3.6% |
| Insomnia |
3.6% |
| Pain In Extremity |
3.6% |
| Syncope |
3.6% |
| Tremor |
3.6% |
| Urticaria |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Constipation |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
60.0% |
| Constipation |
10.0% |
| Diabetes Mellitus |
10.0% |
| Hypertension |
10.0% |
| Insomnia |
10.0% |
|
| Oedema Peripheral |
33.3% |
| Torsade De Pointes |
33.3% |
| Vomiting |
33.3% |
|
